Search for: "Ely Lilly" Results 561 - 580 of 2,157
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Apr 2024, 10:28 am by Dennis Crouch
  Focusing on the evidence presented, Eli Lilly particularly notes how Teva’s [read post]
9 Feb 2010, 11:58 pm
In August 2008 Mr Justice Kitchin delivered a mega-judgment in Eli Lilly & Co v Human Genome Sciences Inc, [2008] EWHC 1903 (Pat) on patent validity (noted by the IPKat here). [read post]
2 Nov 2011, 8:46 pm by Dennis Crouch
Eli Lilly (UK Supreme Court, 2 Nov 2011) [Decision] Case No. [2011] UKSC 51. [read post]
9 Jun 2011, 12:43 pm by Jenna Greene
Covington & Burling lawyers yesterday scored a key win for Eli Lilly and Co. in a dispute over marketing a diabetes drug. [read post]
6 Mar 2009, 7:41 pm
Supreme Court ruled that federal approval of a drug is no protection from lawsuits in state courts over safety issues that arise later -- a decision that could have implications for Eli Lilly and Co. and other pharmaceutical makers. [read post]
10 Jan 2010, 3:53 pm by Levin & Perconti
Last year, Eli Lilly, which markets the drug Zyprexa, paid a $1.4 billion fine and pled guilty to a misdemeanor for promoting its drug to the elderly with dementia. [read post]
2 Feb 2009, 9:07 pm
The new drug in question is called prasugrel and would be marketed by Eli Lilly & Co with potential co-marketing by Japan's Daiichi Sankyo Co., the drug's discoverer.Reports issued suggest that prasugrel may be more effective than Plavix in preventing heart attacks, but also a higher risk to cause dangerous bleeding. [read post]
27 Oct 2011, 11:48 am by Gene Quinn
Exactly who is to blame if a pharmaceutical company, say Eli Lilly, decides to invest billions of dollars and build a facility when they haven't adequately protected their own intellectual property? [read post]
26 Feb 2009, 7:32 am
  Medtronic now joins Eli Lilly & Co. and Pfizer Inc. in making these voluntary disclosures. [read post]
29 Dec 2018, 6:30 am by Sara Moran
Sara MoranApplying the so-called ‘Actavis Questions’ (further to the Supreme Court decision in Actavis v Eli Lilly), the Court of Appeal reached a different conclusion from the Patents Court on the issue of infringement. [read post]
25 Aug 2010, 6:58 am by Christopher T. Hurley
Recently, A federal advisory panel to the Food and Drug Administration “voted narrowly to recommend allowing Eli Lilly to market its blockbuster antidepressant, Cymbalta, for some chronic pain conditions affecting millions of Americans, particularly lower back pain. [read post]